The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results